Biomarkers

PD-L1 TPS

Also known as: PD-L1 expression, Tumor proportion score

Definition

Tumor Proportion Score measuring PD-L1 expression on tumor cells, used to select patients for immunotherapy.

Higher PD-L1 TPS correlates with better response to PD-1/PD-L1 inhibitors in several cancers, guiding monotherapy versus combination approaches.

Immunotherapy

Treatment

PD-1 Inhibitor

Immunotherapy

NSCLC

Oncology

Pembrolizumab injection 100 mg/4 mL (25 mg/mL) - single-use vial for intravenous infusion

3802.5 EUR

Nivolumab concentrate for solution for infusion - 240 mg/24 mL (10 mg/mL) single-use vial

3542 EUR